TG Therapeutics | TGTX - سود ناخالص در فروش

قیمت سهام
33.73
تغییر روزانه
-0.90 -2.60%
ماهیانه
20.25%
سالیانه
-8.12%
Q2 پیش بینی
32.81




سود ناخالص در فروش تغییر دادن تاریخ
AbbVie USD 10.47B 605M 2025-09
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.48B 307M 2025-09
Ardelyx USD 114.37M 8.02M 2025-12
Arrowhead Research USD 256.47M 228.7M 2025-09
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.65B 34.6M 2025-12
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Curis USD 1.14M 8.86M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Infinity Pharmaceuticals USD 231K 59K 2023-06
J&J USD 16.6B 118M 2025-12
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Novartis USD 10.25B 570M 2025-12
Novavax USD 125.04M 76.09M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
TG Therapeutics USD 154.43M 20.81M 2025-12
Verastem USD 14.64M 14.1M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12